Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SLC6A5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | SLC6A5 |
| Aliases | Glycine Transporter 1 |
| Chromosome | 11p15.5 |
| Protein Type | Receptor |
| Function | encodes a 12-transmembrane-domain protein of approximately 635 amino acids. |
| Primary Expression | astrocytes and endothelial cells of the blood-brain barrier |
| Amino Acids | 635 aa |
| GeneCards | SLC6A5 |
| Human Protein Atlas | SLC6A5 |
| N-terminal intracellular domain | Contains regulatory motifs for protein kinase C (PKC) phosphorylation and interaction with scaffolding proteins. |
| Transmembrane core | Forms the substrate-binding pocket (S1 site) and the gated external vestibule. The transporter alternates between outward-facing and inward-facing conformations during the transport cycle. |
| Extracellular loops | Highly glycosylated, with N-linked glycosylation sites essential for proper folding and surface expression. |
| C-terminal intracellular tail | Contains a PDZ-binding motif for interaction with synaptic scaffolding proteins and determines subcellular localization. |
| Glycinergic tone | Steady-state glycine concentrations at glycine receptors |
| NMDA receptor modulation | Glycine is a co-agonist at NMDA-type glutamate receptors; GlyT1 indirectly regulates glutamatergic excitotoxicity through glycine availability |
| Associated Diseases | neurodegeneration |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
SLC6A5["SLC6A5"]
neurodegeneration["neurodegeneration"]
SLC6A5 -->|"implicated_in"| neurodegeneration
style SLC6A5 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SLC6A5 in their description or question text
No additional research found